Intra Cellular Therapies | Devedores Comerciais



Trade Debtors Alterar Data
Acadia Pharmaceuticals USD 113.71M 9.02M 2025-03
ALKERMES USD 321.75M 72.97M 2025-03
Biogen USD 2B 127.7M 2025-03
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Cytokinetics USD 2.01M 14.64M 2025-03
Gilead Sciences USD 4.39B 32M 2025-03
Halozyme Therapeutics USD 304.62M 3.83M 2025-03
J&J USD 16.02B 1.18B 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 7.56B 594M 2024-12
Prothena USD 0 0 2024-12
RedHill Biopharma USD 974K 0 2024-06
Supernus Pharmaceuticals USD 142.08M 3.33M 2024-12
United Therapeutics USD 322M 42.7M 2025-03



Intra Cellular Therapies Devedores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.